Paradoxical Effect of IL-18 Therapy on the Severe and Mild Escherichia coli Infections in Burn-Injured Mice
- 1 August 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 240 (2) , 313-320
- https://doi.org/10.1097/01.sla.0000133354.44709.28
Abstract
To investigate the effects of IL-18 therapy on severe and mild bacterial infection after burn injury. IL-18 therapy restores IFN-γ production in immunosuppressive mice following burn injury and up-regulate host response to LPS and experimental bacterial peritonitis. On the other hand, the overproduction of IFN-γ could induce an exaggerated inflammation. Therefore, in this study, we focus on the beneficial and deleterious effects of IL-18-induced IFN-γ and investigate the behavior of IL-18 in infections. Burn injury was induced in C57BL/6 mice and then they were i.p. injected with IL-18 (0.2 μg) on alternate days. After 1 week, severe and mild infections were made in mice by an Escherichia coli challenge (5 × 108 CFU and 1 × 108 CFU i.v., respectively). IL-18 therapy decreased the mortality of burn-injured mice followed by a severe infection, whereas it unexpectedly increased the mortality of burned mice with a mild infection. The IL-18 therapy increased the number of liver mononuclear cells (MNCs), especially NK cells, and greatly up-regulated the impaired IFN-γ production from the liver and spleen MNCs in mice with severe infection. Both the serum IFN-γ concentrations recovered while the bacterial count in the liver decreased. In contrast, the serum IFN-γ concentrations of the burned mice with mild infection did not decrease in comparison to the unburned mice, whereas IL-18 therapy greatly up-regulated the serum IFN-γ levels in burned mice. However, IL-18 therapy significantly elevated the serum ALT and creatinine levels, thus suggesting that the mortality was induced by an exaggerated form of shock/multiorgan failure. These beneficial and deleterious effects of IL-18 therapy in mice with severe and mild infections, respectively, were all inhibited by anti-IFN-γ Ab pretreatment. IL-18 therapy can be a potent therapeutic tool against severe bacterial infection in immunocompromised hosts, but careful attention should also be paid to its adverse effects.Keywords
This publication has 33 references indexed in Scilit:
- Interleukin-18 Regulates Both Th1 and Th2 ResponsesAnnual Review of Immunology, 2001
- Induction of Global Anergy Rather Than Inhibitory Th2 Lymphokines Mediates Posttrauma T Cell ImmunodepressionClinical Immunology, 2000
- Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injurySurgery, 1996
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Major Injury Leads to Predominance of the T Helper-2 Lymphocyte Phenotype and Diminished Interleukin-12 Production Associated with Decreased Resistance to InfectionAnnals of Surgery, 1995
- Epidemiology of Trauma DeathsThe Journal of Trauma: Injury, Infection, and Critical Care, 1995
- INTERFERON-GAMMA INCREASES MORTALITY FOLLOWING CECAL LIGATION AND PUNCTUREPublished by Wolters Kluwer Health ,1994
- Preferential Activation and Depletion of the Alternative Complement Pathway by Burn InjuryAnnals of Surgery, 1983
- The Incidence of Bacteremia following Burn Wound ExcisionPublished by Wolters Kluwer Health ,1982
- A Physiological Basis for the Development of Opportunistic Infections in ManAnnals of Surgery, 1972